158 related articles for article (PubMed ID: 15182206)
1. The mechanism of action of the fragile histidine triad, Fhit: isolation of a covalent adenylyl enzyme and chemical rescue of H96G-Fhit.
Huang K; Arabshahi A; Wei Y; Frey PA
Biochemistry; 2004 Jun; 43(23):7637-42. PubMed ID: 15182206
[TBL] [Abstract][Full Text] [Related]
2. Engineering human Fhit, a diadenosine triphosphate hydrolase, into an efficient dinucleoside polyphosphate synthase.
Huang K; Frey PA
J Am Chem Soc; 2004 Aug; 126(31):9548-9. PubMed ID: 15291552
[TBL] [Abstract][Full Text] [Related]
3. Stereochemical retention of the configuration in the action of Fhit on phosphorus-chiral substrates.
Abend A; Garrison PN; Barnes LD; Frey PA
Biochemistry; 1999 Mar; 38(12):3668-76. PubMed ID: 10090754
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms.
Garrison PN; Robinson AK; Pekarsky Y; Croce CM; Barnes LD
Biochemistry; 2005 Apr; 44(16):6286-92. PubMed ID: 15835917
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and immunochemical characterisation of human diadenosine triphosphatase provides evidence for its identification with the tumour suppressor Fhit protein.
Asensio AC; Rodríguez-Ferrer CR; Oaknin S; Rotllán P
Biochimie; 2006 May; 88(5):461-71. PubMed ID: 16359767
[TBL] [Abstract][Full Text] [Related]
6. Expression in Escherichia coli and simple purification of human Fhit protein.
Pawelczyk T; Kowara R; Golebiowski F; Matecki A
Protein Expr Purif; 2000 Apr; 18(3):320-6. PubMed ID: 10733886
[TBL] [Abstract][Full Text] [Related]
7. Selective degradation of 2'-adenylated diadenosine tri- and tetraphosphates, Ap(3)A and Ap(4)A, by two specific human dinucleoside polyphosphate hydrolases.
Guranowski A; Galbas M; Hartmann R; Justesen J
Arch Biochem Biophys; 2000 Jan; 373(1):218-24. PubMed ID: 10620341
[TBL] [Abstract][Full Text] [Related]
8. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
Barnes LD; Garrison PN; Siprashvili Z; Guranowski A; Robinson AK; Ingram SW; Croce CM; Ohta M; Huebner K
Biochemistry; 1996 Sep; 35(36):11529-35. PubMed ID: 8794732
[TBL] [Abstract][Full Text] [Related]
9. Kinetic mechanism of UDP-hexose synthase, a point variant of hexose-1-phosphate uridylyltransferase from Escherichia coli.
Ruzicka FJ; Geeganage S; Frey PA
Biochemistry; 1998 Aug; 37(32):11385-92. PubMed ID: 9698386
[TBL] [Abstract][Full Text] [Related]
10. Expression and simple, one-step purification of fragile histidine triad (Fhit) tumor suppressor mutant forms in Escherichia coli and their interaction with protoporphyrin IX.
Zawacka-Pankau J; Podhajska AJ
Biotechnol Lett; 2007 Jun; 29(6):877-83. PubMed ID: 17310323
[TBL] [Abstract][Full Text] [Related]
11. Fragile histidine triad protein: structure, function, and its association with tumorogenesis.
Hassan MI; Naiyer A; Ahmad F
J Cancer Res Clin Oncol; 2010 Mar; 136(3):333-50. PubMed ID: 20033706
[TBL] [Abstract][Full Text] [Related]
12. Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines.
Nakagawa Y; Akao Y
Exp Cell Res; 2006 Aug; 312(13):2433-42. PubMed ID: 16733051
[TBL] [Abstract][Full Text] [Related]
13. Fhit proteins can also recognize substrates other than dinucleoside polyphosphates.
Guranowski A; Wojdyła AM; Pietrowska-Borek M; Bieganowski P; Khurs EN; Cliff MJ; Blackburn GM; Błaziak D; Stec WJ
FEBS Lett; 2008 Sep; 582(20):3152-8. PubMed ID: 18694747
[TBL] [Abstract][Full Text] [Related]
14. Novel reactivity of Fhit proteins: catalysts for fluorolysis of nucleoside 5'-phosphoramidates and nucleoside 5'-phosphosulfates to generate nucleoside 5'-phosphorofluoridates.
Wojdyła-Mamoń AM; Zimny J; Romanowska J; Kraszewski A; Stawinski J; Bieganowski P; Guranowski A
Biochem J; 2015 Jun; 468(2):337-44. PubMed ID: 25826698
[TBL] [Abstract][Full Text] [Related]
15. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
16. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation.
Hussain A; Gutiérrez MI; Timson G; Siraj AK; Deambrogi C; Al-Rasheed M; Gaidano G; Magrath I; Bhatia K
Genes Chromosomes Cancer; 2004 Dec; 41(4):321-9. PubMed ID: 15384174
[TBL] [Abstract][Full Text] [Related]
17. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myeloma.
Takada S; Morita K; Hayashi K; Matsushima T; Sawamura M; Murakami H; Nojima Y
Eur J Haematol; 2005 Dec; 75(6):505-10. PubMed ID: 16313263
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of influence of Ap4A analogues on Fhit-positive HEK293T cells; cytotoxicity and ability to induce apoptosis.
Krakowiak A; Pęcherzewska R; Kaczmarek R; Tomaszewska A; Nawrot B; Stec WJ
Bioorg Med Chem; 2011 Aug; 19(16):5053-60. PubMed ID: 21757356
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles.
Uboldi C; Guidi E; Roperto S; Russo V; Roperto F; Di Meo GP; Iannuzzi L; Floriot S; Boussaha M; Eggen A; Ferretti L
BMC Genomics; 2006 May; 7():123. PubMed ID: 16719907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
